Clinical Trial Update: The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating the combination of a melatonin receptor agonist to reduce or interrupt benzodiazepine and non-benzodiazepine hypnoti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Melatonin receptor agonist

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Chronic Insomnia | Phase 4 | Status: COMPLETED